+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Hepatitis Test Solution/Diagnosis Market by Product Type, Test Type, Technology, Mode of Testing, Application, End User, Hepatitis Type, Disease Stage - Global Forecast 2026-2032- Product Image
Hepatitis Test Solution/Diagnosis Market by Product Type, Test Type, Technology, Mode of Testing, Application, End User, Hepatitis Type, Disease Stage - Global Forecast 2026-2032- Product Image
Sale

Hepatitis Test Solution/Diagnosis Market by Product Type, Test Type, Technology, Mode of Testing, Application, End User, Hepatitis Type, Disease Stage - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904514
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Hepatitis Test Solution/Diagnosis Market is projected to reach USD 4.14 Billion in 2026. It is expected to continue growing at a CAGR of 5.72%, reaching USD 5.79 Billion by 2032.

Viral hepatitis remains one of the most consequential infectious disease burdens for health systems, laboratories, and diagnostic manufacturers. The World Health Organization reported 304 million people living with chronic hepatitis B or C in 2022, with hepatitis-related mortality comparable to major global communicable diseases. This creates sustained demand for hepatitis test solutions spanning screening, confirmatory diagnosis, viral load monitoring, genotyping, point-of-care testing, and laboratory automation.

The hepatitis diagnosis landscape is shaped by public health screening mandates, blood safety requirements, antenatal testing, harm-reduction programs, and growing clinical adoption of nucleic acid testing. High-value sector themes include hepatitis testing, hepatitis diagnosis, HBV testing, HCV testing, liver infection diagnostics, viral hepatitis screening, molecular diagnostics, immunoassay testing, rapid diagnostic testing, and point-of-care hepatitis tests.

Transformative Shifts in the Hepatitis Diagnostics Landscape

The landscape is shifting from episodic, risk-based testing toward broader population screening and integrated care pathways. In the United States, CDC recommendations support universal adult screening for hepatitis B and hepatitis C, while WHO guidance emphasizes expanded diagnosis as a core requirement for viral hepatitis elimination by 2030. These policy changes are increasing demand for scalable serology, rapid diagnostic tests, and high-throughput molecular platforms.

Another major shift is decentralization. Hospitals and reference laboratories remain essential, but community clinics, antenatal programs, prisons, blood banks, and harm-reduction centers increasingly require faster access to reliable hepatitis diagnosis. This favors tests with simplified workflows, lower sample-volume requirements, digital result capture, reflex testing capability, and compatibility with linkage-to-care programs.

Cumulative Impact of Artificial Intelligence on Diagnosis

Artificial intelligence is strengthening hepatitis diagnosis primarily through workflow optimization, patient-risk identification, image-enabled liver assessment, and laboratory decision support. AI can help prioritize high-risk populations, flag abnormal liver enzyme patterns, support reflex testing strategies, and reduce delays between screening and confirmatory diagnosis. These applications align with evidence-based care because final diagnosis still depends on validated immunoassays, molecular tests, and clinician interpretation.

The cumulative impact of AI is expected to be operational rather than substitutive. Laboratories can use predictive analytics to improve test utilization, reduce repeat testing, anticipate reagent needs, and identify care gaps. For diagnostic developers and healthcare providers, AI-enabled platforms may support quality control, automated interpretation, and surveillance analytics, provided systems meet regulatory, privacy, cybersecurity, and clinical validation requirements.

Key Regional Insights Across Major Hepatitis Testing Markets

Asia-Pacific carries a substantial hepatitis B burden, supported by large populations, historical perinatal transmission, and uneven vaccination and birth-dose coverage in several settings. China, India, Japan, South Korea, and Australia show different demand patterns, ranging from high-volume public screening and maternal-child health programs to advanced molecular monitoring and specialist-led liver disease management. North America is characterized by universal screening guidance, strong laboratory capacity, and persistent HCV testing demand linked to injection drug use, aging cohorts, and treatment linkage initiatives.

Europe benefits from mature laboratory infrastructure, surveillance systems, and European Union public health coordination, though diagnosis gaps remain among migrants, underserved communities, incarcerated populations, and people who inject drugs. Latin America is expanding hepatitis testing through blood screening, antenatal care, and public health programs, with Brazil and Mexico anchoring regional diagnostic activity. The Middle East is supported by premarital screening, migrant health programs, centralized healthcare investment, and high-capacity hospital networks, particularly in GCC markets. Africa faces high HBV prevalence in several countries and needs affordable rapid testing, timely birth-dose linkage, safe blood screening, and decentralized molecular access to improve diagnosis and treatment initiation.

Key Group Insights for Hepatitis Testing Demand

ASEAN demand is supported by high population density, expanding universal health coverage, and ongoing HBV prevention programs, with countries prioritizing affordable screening, antenatal testing, and maternal-child health integration. The GCC is more infrastructure-led, with national screening programs, migrant health assessments, medical tourism, and centralized procurement supporting premium diagnostic adoption. The European Union emphasizes surveillance quality, harmonized public health standards, blood safety, and viral hepatitis elimination targets, creating demand for both laboratory automation and outreach testing.

BRICS countries represent a high-volume diagnostic environment because Brazil, Russia, India, China, and South Africa combine sizable populations, varied hepatitis burdens, and expanding domestic diagnostic capabilities. G7 markets drive innovation through regulatory rigor, reimbursement maturity, integrated laboratory networks, and adoption of high-throughput molecular diagnostics. NATO countries overlap heavily with high-income European and North American systems, where military health services, blood safety standards, deployable medical capabilities, and infectious disease readiness reinforce demand for reliable hepatitis testing.

Key Country Insights in Hepatitis Diagnosis

The United States leads in guideline-driven HBV and HCV screening, advanced molecular testing, and large-scale laboratory infrastructure, while Canada emphasizes public health access, Indigenous health priorities, and harm-reduction-linked HCV testing. Mexico and Brazil are important Latin American markets due to population size, blood safety programs, antenatal testing, and expanding public diagnostics. The United Kingdom, Germany, France, Italy, and Spain maintain strong laboratory networks, national health systems, and public health screening capacity, while Russia shows continued need for HBV and HCV diagnosis across a broad geography and diverse care settings.

China and India are central to global hepatitis testing because of their large populations and substantial chronic HBV burden, with rising demand for affordable immunoassays, rapid screening, and molecular confirmation. Japan, Australia, and South Korea represent advanced Asia-Pacific markets with mature screening systems, high-quality laboratories, and strong clinical monitoring for chronic liver disease. Across these countries, progress depends on earlier diagnosis, reflex testing, treatment linkage, digital reporting, and integration of hepatitis screening into routine primary care, antenatal services, blood safety systems, and community outreach.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize validated, scalable, and cost-efficient hepatitis testing portfolios that cover screening, confirmation, viral load monitoring, genotyping where clinically required, and treatment follow-up. Product strategies should align with WHO elimination goals, universal screening trends, blood bank requirements, antenatal care, occupational health protocols, and outreach programs for high-risk and underserved populations.

Organizations should invest in point-of-care and near-patient testing where access barriers remain high, while maintaining high-throughput platforms for centralized laboratories. Partnerships with public health agencies, payers, non-governmental organizations, and digital health providers can improve linkage to care. Leaders should also strengthen regulatory evidence, quality management, local supply resilience, training programs, and AI-enabled workflow tools that improve laboratory productivity without compromising diagnostic accuracy.

Research Methodology and Data Validation

The research methodology integrates secondary research from globally recognized health authorities, including WHO, CDC, ECDC, national health ministries, regulatory agencies, blood safety programs, and peer-reviewed clinical literature. Interpretation considers disease burden, screening recommendations, test adoption, healthcare infrastructure, reimbursement, procurement models, diagnostic technology trends, and the role of laboratory and point-of-care testing.

The analysis is structured to support executive decision-making across product strategy, regional expansion, competitive positioning, and commercialization. Insights are validated through triangulation of epidemiological evidence, policy direction, laboratory practice patterns, regulatory guidance, and technology adoption indicators, ensuring that conclusions remain data-backed and relevant to the hepatitis test solution and diagnosis landscape.

Conclusion: Strategic Outlook for Hepatitis Diagnostics

The hepatitis test solution landscape is positioned for durable relevance as governments and healthcare systems intensify efforts to close diagnosis gaps. With hundreds of millions of people living with chronic hepatitis B or C and many still undiagnosed, reliable screening and confirmatory testing remain essential to reducing liver cirrhosis, hepatocellular carcinoma, transmission risk, and preventable mortality.

Future leadership will depend on accessible testing, laboratory efficiency, regulatory quality, affordability, and faster linkage to care. Organizations that combine validated immunoassay and molecular diagnostics with decentralized access, digital reporting, and AI-supported workflow intelligence will be best positioned to support global viral hepatitis elimination objectives.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Hepatitis Test Solution/Diagnosis Market, by Product Type
7.1. Instruments
7.1.1. Bench-Top Instruments
7.1.2. High-Throughput Instruments
7.2. Kits & Consumables
7.2.1. Test Kits
7.2.2. Assay Reagents
7.3. Software & Services
8. Hepatitis Test Solution/Diagnosis Market, by Test Type
8.1. Serological Tests
8.1.1. Antigen Tests
8.1.2. Antibody Tests
8.2. Molecular / Nucleic Acid Tests
8.3. Rapid Diagnostic Tests (RDTs)
8.3.1. Lateral Flow Assays
8.3.2. Point-of-Care (POC) Kits
8.4. Liver Function Tests (Supportive Diagnostics)
8.4.1. ALT / AST Tests
8.4.2. Bilirubin Tests
8.5. Genotyping & Viral Load Testing
9. Hepatitis Test Solution/Diagnosis Market, by Technology
9.1. Enzyme-Linked Immunosorbent Assay (ELISA)
9.2. Chemiluminescent Immunoassay (CLIA)
9.3. Polymerase Chain Reaction (PCR)
9.4. Isothermal Amplification
9.5. Lateral Flow Immunoassay
9.6. Sequencing Technologies (NGS)
10. Hepatitis Test Solution/Diagnosis Market, by Mode of Testing
10.1. Laboratory-Based Testing
10.2. Point-of-Care (POC) Testing
10.3. Home-Based / Self-Testing
11. Hepatitis Test Solution/Diagnosis Market, by Application
11.1. Screening
11.2. Diagnosis / Confirmation
11.3. Viral Load Monitoring
11.4. Treatment Monitoring & Prognosis
11.5. Epidemiological Surveillance
12. Hepatitis Test Solution/Diagnosis Market, by End User
12.1. Blood Banks
12.2. Diagnostic Laboratories
12.3. Home Care Settings
12.4. Hospitals & Clinics
12.5. Academic & Research Institutes
13. Hepatitis Test Solution/Diagnosis Market, by Hepatitis Type
13.1. Hepatitis A (HAV)
13.2. Hepatitis B (HBV)
13.3. Hepatitis C (HCV)
13.4. Hepatitis D (HDV)
13.5. Hepatitis E (HEV)
14. Hepatitis Test Solution/Diagnosis Market, by Disease Stage
14.1. Acute Infection Testing
14.2. Chronic Infection Monitoring
14.3. Post-Treatment Monitoring
15. Asia-Pacific Hepatitis Test Solution/Diagnosis Market
16. North America Hepatitis Test Solution/Diagnosis Market
17. Latin America Hepatitis Test Solution/Diagnosis Market
18. Europe Hepatitis Test Solution/Diagnosis Market
19. Middle East Hepatitis Test Solution/Diagnosis Market
20. Africa Hepatitis Test Solution/Diagnosis Market
21. ASEAN Hepatitis Test Solution/Diagnosis Market
22. GCC Hepatitis Test Solution/Diagnosis Market
23. European Union Hepatitis Test Solution/Diagnosis Market
24. BRICS Hepatitis Test Solution/Diagnosis Market
25. G7 Hepatitis Test Solution/Diagnosis Market
26. NATO Hepatitis Test Solution/Diagnosis Market
27. United States Hepatitis Test Solution/Diagnosis Market
28. Canada Hepatitis Test Solution/Diagnosis Market
29. Mexico Hepatitis Test Solution/Diagnosis Market
30. Brazil Hepatitis Test Solution/Diagnosis Market
31. United Kingdom Hepatitis Test Solution/Diagnosis Market
32. Germany Hepatitis Test Solution/Diagnosis Market
33. France Hepatitis Test Solution/Diagnosis Market
34. Russia Hepatitis Test Solution/Diagnosis Market
35. Italy Hepatitis Test Solution/Diagnosis Market
36. Spain Hepatitis Test Solution/Diagnosis Market
37. China Hepatitis Test Solution/Diagnosis Market
38. India Hepatitis Test Solution/Diagnosis Market
39. Japan Hepatitis Test Solution/Diagnosis Market
40. Australia Hepatitis Test Solution/Diagnosis Market
41. South Korea Hepatitis Test Solution/Diagnosis Market
42. Competitive Landscape
42.1. Market Concentration Analysis, 2025
42.1.1. Concentration Ratio (CR)
42.1.2. Herfindahl Hirschman Index (HHI)
42.2. Recent Developments & Impact Analysis, 2025
42.3. Product Portfolio Analysis, 2025
42.4. Benchmarking Analysis, 2025
43. Company Profiles
43.1. Abbott Laboratories
43.2. ACON Laboratories, Inc.
43.3. Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
43.4. Bio-Rad Laboratories, Inc.
43.5. BioCheck, Inc.
43.6. bioMérieux SA
43.7. CTK Biotech, Inc.
43.8. Danaher Corporation
43.9. DIALAB GmbH
43.10. DiaSorin S.p.A.
43.11. Getein Biotech, Inc.
43.12. Guangzhou Wondfo Biotech Co., Ltd.
43.13. H.U. Group Holdings, Inc.
43.14. Hangzhou AllTest Biotech Co., Ltd.
43.15. Hologic, Inc.
43.16. HUMAN Gesellschaft für Biochemica und Diagnostica mbH
43.17. InTec PRODUCTS, INC.
43.18. J. Mitra & Co. Pvt. Ltd.
43.19. Jiangsu BioPerfectus Technologies Co., Ltd.
43.20. Maccura Biotechnology Co., Ltd.
43.21. Meril Life Sciences Pvt. Ltd.
43.22. OraSure Technologies, Inc.
43.23. Premier Medical Corporation Private Limited
43.24. QIAGEN N.V.
43.25. QuidelOrtho Corporation
43.26. Revvity, Inc.
43.27. Roche Holding Ltd
43.28. Sansure Biotech Inc.
43.29. Seegene Inc.
43.30. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
43.31. Shenzhen New Industries Biomedical Engineering Co., Ltd.
43.32. Siemens Healthineers AG
43.33. Sysmex Corporation
43.34. Transasia Bio-Medicals Ltd.
43.35. Tulip Diagnostics (P) Ltd.
List of Figures
FIGURE 1. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
FIGURE 17. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MODE OF TESTING, 2025 VS 2032 (%)
FIGURE 21. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MODE OF TESTING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 23. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 25. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS TYPE, 2025 VS 2032 (%)
FIGURE 27. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE STAGE, 2025 VS 2032 (%)
FIGURE 29. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE STAGE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. NORTH AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. NORTH AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. LATIN AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. LATIN AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. EUROPE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 37. EUROPE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. MIDDLE EAST HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 39. MIDDLE EAST HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 41. AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. ASEAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. ASEAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. GCC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. GCC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. EUROPEAN UNION HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. EUROPEAN UNION HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. BRICS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 49. BRICS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 50. G7 HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 51. G7 HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 52. NATO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 53. NATO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 54. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. UNITED KINGDOM HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. GERMANY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. FRANCE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. RUSSIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. ITALY HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 63. SPAIN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 64. CHINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 65. INDIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 66. JAPAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 67. AUSTRALIA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 68. SOUTH KOREA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BENCH-TOP INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BENCH-TOP INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BENCH-TOP INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL HIGH-THROUGHPUT INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL HIGH-THROUGHPUT INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL HIGH-THROUGHPUT INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL KITS & CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL KITS & CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL KITS & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ASSAY REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ASSAY REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ASSAY REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL SEROLOGICAL TESTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL SEROLOGICAL TESTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL SEROLOGICAL TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ANTIGEN TESTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ANTIGEN TESTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ANTIGEN TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ANTIBODY TESTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ANTIBODY TESTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ANTIBODY TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL MOLECULAR / NUCLEIC ACID TESTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL MOLECULAR / NUCLEIC ACID TESTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL MOLECULAR / NUCLEIC ACID TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL RAPID DIAGNOSTIC TESTS (RDTS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL RAPID DIAGNOSTIC TESTS (RDTS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL RAPID DIAGNOSTIC TESTS (RDTS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL LATERAL FLOW ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL POINT-OF-CARE (POC) KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL POINT-OF-CARE (POC) KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL POINT-OF-CARE (POC) KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL LIVER FUNCTION TESTS (SUPPORTIVE DIAGNOSTICS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL LIVER FUNCTION TESTS (SUPPORTIVE DIAGNOSTICS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL LIVER FUNCTION TESTS (SUPPORTIVE DIAGNOSTICS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ALT / AST TESTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ALT / AST TESTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ALT / AST TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BILIRUBIN TESTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BILIRUBIN TESTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BILIRUBIN TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL GENOTYPING & VIRAL LOAD TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL GENOTYPING & VIRAL LOAD TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL GENOTYPING & VIRAL LOAD TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CHEMILUMINESCENT IMMUNOASSAY (CLIA) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CHEMILUMINESCENT IMMUNOASSAY (CLIA) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CHEMILUMINESCENT IMMUNOASSAY (CLIA) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ISOTHERMAL AMPLIFICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ISOTHERMAL AMPLIFICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ISOTHERMAL AMPLIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL LATERAL FLOW IMMUNOASSAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL LATERAL FLOW IMMUNOASSAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL LATERAL FLOW IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL SEQUENCING TECHNOLOGIES (NGS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL SEQUENCING TECHNOLOGIES (NGS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL SEQUENCING TECHNOLOGIES (NGS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL LABORATORY-BASED TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL LABORATORY-BASED TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL LABORATORY-BASED TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL POINT-OF-CARE (POC) TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL POINT-OF-CARE (POC) TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL POINT-OF-CARE (POC) TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL HOME-BASED / SELF-TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL HOME-BASED / SELF-TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL HOME-BASED / SELF-TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL DIAGNOSIS / CONFIRMATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL DIAGNOSIS / CONFIRMATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL DIAGNOSIS / CONFIRMATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL VIRAL LOAD MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL VIRAL LOAD MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL VIRAL LOAD MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL TREATMENT MONITORING & PROGNOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL TREATMENT MONITORING & PROGNOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL TREATMENT MONITORING & PROGNOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL EPIDEMIOLOGICAL SURVEILLANCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL EPIDEMIOLOGICAL SURVEILLANCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL EPIDEMIOLOGICAL SURVEILLANCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL BLOOD BANKS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL BLOOD BANKS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL BLOOD BANKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS TYPE, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL HEPATITIS A (HAV) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL HEPATITIS A (HAV) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL HEPATITIS A (HAV) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL HEPATITIS B (HBV) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL HEPATITIS B (HBV) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL HEPATITIS B (HBV) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL HEPATITIS C (HCV) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL HEPATITIS C (HCV) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL HEPATITIS C (HCV) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL HEPATITIS D (HDV) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL HEPATITIS D (HDV) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL HEPATITIS D (HDV) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL HEPATITIS E (HEV) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL HEPATITIS E (HEV) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL HEPATITIS E (HEV) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE STAGE, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL ACUTE INFECTION TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL ACUTE INFECTION TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL ACUTE INFECTION TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL CHRONIC INFECTION MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL CHRONIC INFECTION MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL CHRONIC INFECTION MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL POST-TREATMENT MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL POST-TREATMENT MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL POST-TREATMENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS (RDTS), 2018-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY LIVER FUNCTION TESTS (SUPPORTIVE DIAGNOSTICS), 2018-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS TYPE, 2018-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE STAGE, 2018-2032 (USD MILLION)
TABLE 165. NORTH AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 166. NORTH AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 167. NORTH AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 168. NORTH AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 169. NORTH AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 170. NORTH AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2032 (USD MILLION)
TABLE 171. NORTH AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS (RDTS), 2018-2032 (USD MILLION)
TABLE 172. NORTH AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY LIVER FUNCTION TESTS (SUPPORTIVE DIAGNOSTICS), 2018-2032 (USD MILLION)
TABLE 173. NORTH AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 174. NORTH AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
TABLE 175. NORTH AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 176. NORTH AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 177. NORTH AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS TYPE, 2018-2032 (USD MILLION)
TABLE 178. NORTH AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE STAGE, 2018-2032 (USD MILLION)
TABLE 179. LATIN AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 180. LATIN AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 181. LATIN AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 182. LATIN AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 183. LATIN AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 184. LATIN AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2032 (USD MILLION)
TABLE 185. LATIN AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS (RDTS), 2018-2032 (USD MILLION)
TABLE 186. LATIN AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY LIVER FUNCTION TESTS (SUPPORTIVE DIAGNOSTICS), 2018-2032 (USD MILLION)
TABLE 187. LATIN AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 188. LATIN AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
TABLE 189. LATIN AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 190. LATIN AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 191. LATIN AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS TYPE, 2018-2032 (USD MILLION)
TABLE 192. LATIN AMERICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE STAGE, 2018-2032 (USD MILLION)
TABLE 193. EUROPE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 194. EUROPE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 195. EUROPE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 196. EUROPE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 197. EUROPE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 198. EUROPE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2032 (USD MILLION)
TABLE 199. EUROPE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS (RDTS), 2018-2032 (USD MILLION)
TABLE 200. EUROPE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY LIVER FUNCTION TESTS (SUPPORTIVE DIAGNOSTICS), 2018-2032 (USD MILLION)
TABLE 201. EUROPE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 202. EUROPE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
TABLE 203. EUROPE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 204. EUROPE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 205. EUROPE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS TYPE, 2018-2032 (USD MILLION)
TABLE 206. EUROPE HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE STAGE, 2018-2032 (USD MILLION)
TABLE 207. MIDDLE EAST HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 208. MIDDLE EAST HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 209. MIDDLE EAST HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 210. MIDDLE EAST HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 211. MIDDLE EAST HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 212. MIDDLE EAST HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2032 (USD MILLION)
TABLE 213. MIDDLE EAST HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS (RDTS), 2018-2032 (USD MILLION)
TABLE 214. MIDDLE EAST HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY LIVER FUNCTION TESTS (SUPPORTIVE DIAGNOSTICS), 2018-2032 (USD MILLION)
TABLE 215. MIDDLE EAST HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 216. MIDDLE EAST HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
TABLE 217. MIDDLE EAST HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 218. MIDDLE EAST HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 219. MIDDLE EAST HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS TYPE, 2018-2032 (USD MILLION)
TABLE 220. MIDDLE EAST HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE STAGE, 2018-2032 (USD MILLION)
TABLE 221. AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 222. AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 223. AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 224. AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 225. AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 226. AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2032 (USD MILLION)
TABLE 227. AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS (RDTS), 2018-2032 (USD MILLION)
TABLE 228. AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY LIVER FUNCTION TESTS (SUPPORTIVE DIAGNOSTICS), 2018-2032 (USD MILLION)
TABLE 229. AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 230. AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
TABLE 231. AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 232. AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 233. AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS TYPE, 2018-2032 (USD MILLION)
TABLE 234. AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE STAGE, 2018-2032 (USD MILLION)
TABLE 235. ASEAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 236. ASEAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 237. ASEAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 238. ASEAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 239. ASEAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 240. ASEAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2032 (USD MILLION)
TABLE 241. ASEAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS (RDTS), 2018-2032 (USD MILLION)
TABLE 242. ASEAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY LIVER FUNCTION TESTS (SUPPORTIVE DIAGNOSTICS), 2018-2032 (USD MILLION)
TABLE 243. ASEAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 244. ASEAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
TABLE 245. ASEAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 246. ASEAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 247. ASEAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS TYPE, 2018-2032 (USD MILLION)
TABLE 248. ASEAN HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE STAGE, 2018-2032 (USD MILLION)
TABLE 249. GCC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 250. GCC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 251. GCC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 252. GCC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 253. GCC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 254. GCC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2032 (USD MILLION)
TABLE 255. GCC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS (RDTS), 2018-2032 (USD MILLION)
TABLE 256. GCC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY LIVER FUNCTION TESTS (SUPPORTIVE DIAGNOSTICS), 2018-2032 (USD MILLION)
TABLE 257. GCC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 258. GCC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
TABLE 259. GCC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 260. GCC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 261. GCC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS TYPE, 2018-2032 (USD MILLION)
TABLE 262. GCC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE STAGE, 2018-2032 (USD MILLION)
TABLE 263. EUROPEAN UNION HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 264. EUROPEAN UNION HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 265. EUROPEAN UNION HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 266. EUROPEAN UNION HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 267. EUROPEAN UNION HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 268. EUROPEAN UNION HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2032 (USD MILLION)
TABLE 269. EUROPEAN UNION HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS (RDTS), 2018-2032 (USD MILLION)
TABLE 270. EUROPEAN UNION HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY LIVER FUNCTION TESTS (SUPPORTIVE DIAGNOSTICS), 2018-2032 (USD MILLION)
TABLE 271. EUROPEAN UNION HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 272. EUROPEAN UNION HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
TABLE 273. EUROPEAN UNION HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 274. EUROPEAN UNION HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 275. EUROPEAN UNION HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS TYPE, 2018-2032 (USD MILLION)
TABLE 276. EUROPEAN UNION HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE STAGE, 2018-2032 (USD MILLION)
TABLE 277. BRICS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 278. BRICS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 279. BRICS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 280. BRICS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 281. BRICS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 282. BRICS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2032 (USD MILLION)
TABLE 283. BRICS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS (RDTS), 2018-2032 (USD MILLION)
TABLE 284. BRICS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY LIVER FUNCTION TESTS (SUPPORTIVE DIAGNOSTICS), 2018-2032 (USD MILLION)
TABLE 285. BRICS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 286. BRICS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
TABLE 287. BRICS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 288. BRICS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 289. BRICS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS TYPE, 2018-2032 (USD MILLION)
TABLE 290. BRICS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE STAGE, 2018-2032 (USD MILLION)
TABLE 291. G7 HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 292. G7 HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 293. G7 HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 294. G7 HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 295. G7 HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 296. G7 HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2032 (USD MILLION)
TABLE 297. G7 HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS (RDTS), 2018-2032 (USD MILLION)
TABLE 298. G7 HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY LIVER FUNCTION TESTS (SUPPORTIVE DIAGNOSTICS), 2018-2032 (USD MILLION)
TABLE 299. G7 HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 300. G7 HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
TABLE 301. G7 HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 302. G7 HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 303. G7 HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS TYPE, 2018-2032 (USD MILLION)
TABLE 304. G7 HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE STAGE, 2018-2032 (USD MILLION)
TABLE 305. NATO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 306. NATO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 307. NATO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 308. NATO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 309. NATO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 310. NATO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2032 (USD MILLION)
TABLE 311. NATO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RAPID DIAGNOSTIC TESTS (RDTS), 2018-2032 (USD MILLION)
TABLE 312. NATO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY LIVER FUNCTION TESTS (SUPPORTIVE DIAGNOSTICS), 2018-2032 (USD MILLION)
TABLE 313. NATO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 314. NATO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MODE OF TESTING, 2018-2032 (USD MILLION)
TABLE 315. NATO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 316. NATO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 317. NATO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HEPATITIS TYPE, 2018-2032 (USD MILLION)
TABLE 318. NATO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DISEASE STAGE, 2018-2032 (USD MILLION)
TABLE 319. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 320. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 321. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 322. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & CONSUMABLES, 2018-2032 (USD MILLION)
TABLE 323. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 324. UNITED STATES HEPATITIS TEST

Companies Mentioned

The companies featured in this Hepatitis Test Solution/Diagnosis market report include:
  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • BioCheck, Inc.
  • bioMérieux SA
  • CTK Biotech, Inc.
  • Danaher Corporation
  • DIALAB GmbH
  • DiaSorin S.p.A.
  • Getein Biotech, Inc.
  • Guangzhou Wondfo Biotech Co., Ltd.
  • H.U. Group Holdings, Inc.
  • Hangzhou AllTest Biotech Co., Ltd.
  • Hologic, Inc.
  • HUMAN Gesellschaft für Biochemica und Diagnostica mbH
  • InTec PRODUCTS, INC.
  • J. Mitra & Co. Pvt. Ltd.
  • Jiangsu BioPerfectus Technologies Co., Ltd.
  • Maccura Biotechnology Co., Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • OraSure Technologies, Inc.
  • Premier Medical Corporation Private Limited
  • QIAGEN N.V.
  • QuidelOrtho Corporation
  • Revvity, Inc.
  • Roche Holding Ltd
  • Sansure Biotech Inc.
  • Seegene Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Shenzhen New Industries Biomedical Engineering Co., Ltd.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Transasia Bio-Medicals Ltd.
  • Tulip Diagnostics (P) Ltd.

Table Information

Report AttributeDetails
No. of Pages198
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 4.14 Billion
Forecasted Market Value ( USD ) by 2032 $ 5.79 Billion
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned36

Related Topics

Related Reports

Hepatitis Test Solution/Diagnosis - Global Strategic Business Report - Product Image

Hepatitis Test Solution/Diagnosis - Global Strategic Business Report

  • Report
  • 275 Pages
  • Global
From
Hepatitis Testing - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Image

Hepatitis Testing - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Report
  • 150 Pages
  • Global
From
Viral Hepatitis Test Kit Market - Global Forecast 2025-2030 - Product Image

Viral Hepatitis Test Kit Market - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Hepatitis Diagnostic Tests Market Report 2026 - Product Image

Hepatitis Diagnostic Tests Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Hepatitis B and C Diagnostics Market - Global Strategic Business Report - Product Image

Hepatitis B and C Diagnostics Market - Global Strategic Business Report

  • Report
  • 275 Pages
  • Global
From

About the Hepatitis Test Solution Diagnosis Market

In the realm of infectious disease testing, the hepatitis test solution diagnosis market comprises a segment focused on detecting and quantifying the presence of hepatitis infections, which include Hepatitis A, B, C, D, and E. Diagnosis of these conditions is critical due to their impact on liver function and potential for causing liver disease, cirrhosis, or carcinoma. The market includes a variety of testing modalities such as immunoassay-based tests, PCR-based tests, and point-of-care testing platforms. These diagnostic tools help in screening blood donations, monitoring the disease, and managing treatment regimens for infected patients. Advances in biotechnology have led to the development of more rapid and sensitive tests, facilitating early detection and improved patient outcomes. Numerous enterprises partake in the hepatitis test solution diagnosis market. Some notable companies include Abbott Laboratories, known for their range of immunoassays and laboratory equipment; Roche Diagnostics, offering advanced molecular assays; Siemens Healthineers, providing a comprehensive suite of diagnostic solutions; and QIAGEN, which supplies technologies for nucleic acid amplification testing. Additionally, Bio-Rad Laboratories and Beckman Coulter offer a variety of testing reagents and instruments that support hepatitis diagnosis. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.